Conmed (CNMD) Capital Expenditures (2010 - 2026)

Conmed's Capital Expenditures history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• Quarterly Capital Expenditures fell 23.47% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (up 27.59% YoY) and the FY2025 annual result came in at $19.8 million, up 51.38% from the prior year.
• Capital Expenditures was $2.9 million for Q1 2026 at Conmed, down from $5.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $6.7 million in Q3 2022 and bottomed at $2.0 million in Q1 2024.
• A 5-year average of $4.5 million and a median of $4.5 million in 2023 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures jumped 90.75% — and 2024, when it slumped 52.16%.
• Conmed's Capital Expenditures stood at $5.7 million in 2022, then decreased by 14.46% to $4.9 million in 2023, then retreated by 16.79% to $4.0 million in 2024, then increased by 26.51% to $5.1 million in 2025, then slumped by 43.42% to $2.9 million in 2026.
• Business Quant data shows CNMD's Capital Expenditures at $2.9 million in Q1 2026, $5.1 million in Q4 2025, and $5.2 million in Q3 2025.